Drug class
Iodine-123 labelled dopamine transporter (DAT) radioligand; diagnostic radiopharmaceutical
Mechanism of action
Ioflupane binds to dopamine transporters on presynaptic dopaminergic nerve terminals in the striatum. After labelling with iodine-123, its regional distribution is visualised using SPECT; reduced striatal uptake indicates loss of functional dopaminergic terminals.
General use cases
- Diagnostic SPECT imaging in adults with clinically uncertain parkinsonian syndromes to help differentiate essential tremor from presynaptic parkinsonian syndromes
- Adjunctive imaging to help differentiate probable dementia with Lewy bodies from Alzheimer’s disease; the scan does not distinguish Parkinson’s disease from multiple system atrophy or progressive supranuclear palsy
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
